~9 spots leftby Apr 2026

Low-Fat Diet + Fish Oil for Prostate Cancer

Recruiting in Palo Alto (17 mi)
WA
Overseen byWilliam Aronson
Age: 18+
Sex: Male
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Jonsson Comprehensive Cancer Center
No Placebo Group

Trial Summary

What is the purpose of this trial?

This randomized phase II trial will evaluate if a low omega-6, high omega-3 fat diet combined with fish oil has the potential to delay disease progression in patients with prostate cancer undergoing active surveillance.

Research Team

WA

William Aronson

Principal Investigator

Jonsson Comprehensive Cancer Center

Eligibility Criteria

This trial is for men with prostate cancer who are on active surveillance, have a Gleason grade of 3+4 or less, and a PSA level under 20. They must not consume certain supplements or fish oil capsules during the study and be able to visit UCLA for check-ups. Men who've had prior prostate cancer treatments or take specific medications can't join.

Inclusion Criteria

Patients sign the informed consent
I agree not to take fish oil capsules if placed in the control group.
PSA < 20
See 6 more

Exclusion Criteria

I have taken finasteride or dutasteride in the last year.
I have had treatment for prostate cancer before.
My prostate cancer was found in just one biopsy core and affects less than 5% of that sample.
See 3 more

Treatment Details

Interventions

  • Behavioral Dietary Intervention (Behavioral)
  • Omega-3 Fatty Acid (Omega-3 Fatty Acid)
Trial OverviewThe trial is testing if a low-fat diet combined with fish oil supplements can slow down prostate cancer progression in patients opting for active surveillance rather than immediate treatment.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm II (fish oil)Experimental Treatment3 Interventions
Patients receive dietary counseling with research dietitian weekly for 1 month and then monthly for 11 months. Patients are given guidelines with recommended meals to follow a low omega-6, high omega-3 fat diet combined with fish oil. Patients also receive 4 fish oil capsules per day PO for 1 year.
Group II: Arm I (control)Active Control1 Intervention
Patients receive no intervention.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Jonsson Comprehensive Cancer Center

Lead Sponsor

Trials
373
Recruited
35,200+
Dr. Aparna Bhaduri profile image

Dr. Aparna Bhaduri

Jonsson Comprehensive Cancer Center

Chief Medical Officer since 2024

MD

Dr. Michael A. Teitell profile image

Dr. Michael A. Teitell

Jonsson Comprehensive Cancer Center

Chief Executive Officer since 2024

MD, PhD

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+
Dr. Douglas R. Lowy profile image

Dr. Douglas R. Lowy

National Cancer Institute (NCI)

Chief Executive Officer since 2023

MD from New York University School of Medicine

Dr. Monica Bertagnolli profile image

Dr. Monica Bertagnolli

National Cancer Institute (NCI)

Chief Medical Officer since 2022

MD from Harvard Medical School

Pharmavite LLC

Industry Sponsor

Trials
12
Recruited
27,200+

Seafood Industry Research Fund

Collaborator

Trials
2
Recruited
210+